- Home
- DY vs JAZZ Comparison
DY vs JAZZ Comparison
Compare DY & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DY
- JAZZ
- Stock Information
- Founded
- DY 1969
- JAZZ 2003
- Country
- DY United States
- JAZZ Ireland
- Employees
- DY N/A
- JAZZ N/A
- Industry
- DY Water Sewer Pipeline Comm & Power Line Construction
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- DY Industrials
- JAZZ Health Care
- Exchange
- DY Nasdaq
- JAZZ Nasdaq
- Market Cap
- DY 7.3B
- JAZZ 7.9B
- IPO Year
- DY N/A
- JAZZ 2007
- Fundamental
- Price
- DY $287.66
- JAZZ $137.41
- Analyst Decision
- DY Strong Buy
- JAZZ Strong Buy
- Analyst Count
- DY 11
- JAZZ 14
- Target Price
- DY $266.36
- JAZZ $179.21
- AVG Volume (30 Days)
- DY 394.4K
- JAZZ 758.5K
- Earning Date
- DY 11-19-2025
- JAZZ 11-05-2025
- Dividend Yield
- DY N/A
- JAZZ N/A
- EPS Growth
- DY 10.50
- JAZZ N/A
- EPS
- DY 8.89
- JAZZ N/A
- Revenue
- DY $4,993,083,000.00
- JAZZ $4,086,695,000.00
- Revenue This Year
- DY $17.12
- JAZZ $5.70
- Revenue Next Year
- DY $8.46
- JAZZ $6.16
- P/E Ratio
- DY $32.20
- JAZZ N/A
- Revenue Growth
- DY 12.61
- JAZZ 4.52
- 52 Week Low
- DY $131.37
- JAZZ $95.49
- 52 Week High
- DY $300.00
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- DY 58.70
- JAZZ 64.86
- Support Level
- DY $281.71
- JAZZ $134.26
- Resistance Level
- DY $292.00
- JAZZ $140.39
- Average True Range (ATR)
- DY 8.32
- JAZZ 3.05
- MACD
- DY 0.42
- JAZZ 0.35
- Stochastic Oscillator
- DY 56.83
- JAZZ 75.62
About DY Dycom Industries Inc.
Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. Its operating companies supply telecommunications providers with a comprehensive portfolio of specialty services, including program management; planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services and provide underground facility locating services for various utilities, including telecommunications providers, and others. It also provides a range of construction, maintenance, and installation services, including the placement and splicing of fiber, copper, and coaxial cables. It provides services throughout the United States.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.